Related Experiment Video

Updated: Jul 13, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid

A T Kessler1, A P Kourtis

  • 1Department of Medicine, Northside-Cherokee Hospital, Atlanta, GA 30013, USA. sandrok@pol.net

Infection
|July 25, 2007
PubMed

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) central nervous system (CNS) infections are difficult to treat. This report details a successful fourth case of MRSA CNS infection treated with linezolid, highlighting the need for clinical trials.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Neuroscience

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) presents a growing challenge in both hospital and community settings.
  • Central nervous system (CNS) infections caused by MRSA are particularly difficult to manage due to limited therapeutic options.

Observation:

  • Linezolid, a novel antibiotic, exhibits potent activity against Gram-positive bacteria, including MRSA.
  • This antibiotic demonstrates favorable penetration into the cerebrospinal fluid (CSF), a critical factor for treating CNS infections.

Findings:

  • The study presents a fourth reported case of successful treatment of a CNS infection attributed to MRSA using linezolid.
  • This case adds to a small but significant body of evidence supporting linezolid's efficacy in this context.

Implications:

  • The findings underscore the potential role of linezolid in managing challenging MRSA CNS infections.
  • There is an urgent need for comprehensive clinical trials to establish definitive guidelines for linezolid's use in treating CNS infections.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...